Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma

Nick W Liu1, Thomas Sanford, Ramaprasad Srinivasan

  • 1Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.

Abstract

Insights

Ischemia and tissue handling significantly alter gene expression in kidney cancer, even with preserved RNA integrity. Careful attention to pre-acquisition variables is crucial for accurate renal cell carcinoma tumor profiling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Ischemia is known to alter gene expression in various tissues.
  • Previous research has not specifically evaluated ischemia's effects on renal tumors.
  • Understanding these effects is vital for accurate molecular profiling of kidney cancer.

Purpose of the Study:

  • To investigate the impact of ischemia on RNA integrity and gene expression in renal cell carcinoma.
  • To evaluate the influence of tissue procurement conditions on these molecular changes.
  • To establish best practices for sample handling in renal tumor research.

Main Methods:

  • Ten renal clear cell carcinoma tumors were resected without clamping.
  • Tumor samples were snap-frozen immediately or stored at various temperatures (4°C, 22°C, 37°C) for up to 240 minutes.
  • RNA integrity was assessed, and gene expression changes were analyzed using microarrays and statistical tests.

Main Results:

  • RNA integrity was maintained for up to 4 hours post-resection, even at 37°C.
  • Over 4,000 genes showed significant expression alterations due to ischemia time and storage conditions.
  • Warmer temperatures and longer ischemia times resulted in the most substantial gene expression changes.

Conclusions:

  • Kidney cancer RNA remains intact for several hours post-surgery, irrespective of storage conditions.
  • Despite RNA stability, ischemia duration and procurement conditions significantly impact gene expression profiles.
  • Precise pre-acquisition variable control is essential for reliable renal tumor profiling.